期刊文献+

基于网络分析的天麻钩藤饮防治高血压的关键靶标挖掘 被引量:5

Potential targets of Tianma Gouteng decoction in treating hypertension diseases through network analysis
下载PDF
导出
摘要 目的挖掘天麻钩藤饮治疗高血压疾病的潜在作用靶标,为进一步研究该方治疗高血压疾病的机制提供思路。方法构建天麻钩藤饮的数据库;构建基于疾病的靶标-靶标网络,通过网络分析方法关键靶标,并在此基础上构建相应的化学成分-靶标-疾病核心网络。结果该复方对肿瘤、循环系统和精神行为障碍等疾病具有潜在的治疗作用;网络挖掘分析得到COX-2和ADRB2两个关键靶标,在此基础上构建了天麻钩藤饮化学成分-靶标-疾病核心网络。结论网络分析方法有助于挖掘天麻钩藤饮治疗高血压疾病的潜在作用靶标,为深入研究其作用机制提供参考。 Objective To excavate the potential targets of Tianma Gouteng decoction in treating hypertension for further study of the action mechanism at the molecule and system levels by network analysis. Methods The database of Tianma Gouteng decoction was established. We further constructed the target-target network based on the shared diseases in the database and excavated the important targets through network analysis. Based on the two important targets,we constructed the chemical component-target-disease network. Results COX-2 and ADRB2 were excavated from target-target network as the important targets,which may be important targets involved in hypertension. Conclusion The network analysis method is helpful to excavate potential targets of Tianma Gouteng decoction in treating hypertension and provide methodological reference for revealing the mechanism of traditional Chinese medicinal formulae.
出处 《广东药学院学报》 CAS 2015年第3期362-366,共5页 Academic Journal of Guangdong College of Pharmacy
基金 广东中山市科技局课题(20101H017) 国家"重大新药创制"科技专项(2012ZX09301003-002-001) 国家科技支撑计划课题(2012BAI29B07) 贵州省剑河中药材产业科技合作计划项目(剑科合字[2014]4号)
关键词 网络药理学 天麻钩藤饮 高血压 靶标-靶标网络 成分-靶标-疾病网络 network pharmacology Tianma Gouteng decoction hypertension target-target network chemical component-target-disease network
  • 相关文献

参考文献14

二级参考文献102

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2Guidelines subeommittee 1999 World Health Organization. International Society of Hypertension Guide lines for the management of Hypertension. Hypertension, 1999, 7(2):97- 100
  • 3Muzykantov VR.Tavgeting of superoxide dismutase and catalase to vascular endothelilm, J Control Release ,2001,71(1):6- 21
  • 4Sagar S ,Kallo IL,Kaul N ,et al .Oxygen free radieals in essential hypertention .Mol Cell Biochem, 1992,111:103- 108
  • 5Funk CD, FitzGerald GA. COX-2 inhibitors and cardiovascular risk. J Cardiovasc Pharmacol, 2007, 50(5): 470-9.
  • 6Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem, 2000, 69: 145-82.
  • 7Yu Y, Fan JJ, Chen XS, et al. Genetic model of selective COX2 inhibition reveals novel heterodimer signaling. Nat Med, 2006, 12(6): 699-704.
  • 8Yu Y, Funk CD. A novel genetic model of selective COX-2 inhibition: comparison with COX-2 null mice. Prostaglandins Other Lipid Mediat, 2007, 82(1-4): 77-84.
  • 9FitzGerald GA, Loll P. COX in a crystal ball: current status and future promise of prostaglandin research. J Clin Invest, 2001, 107(11): 1335-7.
  • 10Smyth EM, Grosser T, Wang M, et al. Prostanoids in health and disease. J Lipid Res, 2009, 50(Suppl): S423-8.

共引文献119

同被引文献108

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部